George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The purpose of this synopsis is to notify industry that the United States Nuclear Regulatory Commission (U.S. NRC) intents to award a Purchase Order without providing for full or open competition under the authority of FAR 13.106-1 (b)(1)(i) "Soliciting from a Single Source." This notice of intent is neither a request for quotes nor a solicitation for offers. If awarded, the sole source purchase order will be issued to the following company: Stilo International Windmill Hill Business Park Whitehill Way, Swindon Wiltshire SN5 6QR United Kingdom The purpose of this acquisition is to obtain 100 AuthorBridge software licenses. AuthorBridge is a browser-based, enterprise Darwin Information Typing Architecture (DITA) compliant, web-based XML authoring tool. AuthorBridge was developed by Stilo and is an easy to use HTML editor that supports XML and is an integral component of the Review Management System (RMS). Several products were reviewed as part of the market research to find a DITA (Darwin Information Typing Architecture) compliant, web-based XML editor. The result of market research was that Stilo provides in their product, AuthorBridge, a unique combination of interoperability with IBM P8 Case Manager, on the fly translation from HTML to XML and back again, and an intuitive and very easy to use user interface, which all meets the current needs of the U.S. NRC.
The window of opportunity to buy STL shares at just 7 pence seems to be closing. 8 pence levels are looming imo,possibly in the next couple of weeks.
The resignation,by mutual agreement, of Richard Alsept, from his position as Director, CFO and Company Secretary of Stilo International, could be construed a bullish indicator,for it represents a further "clearing of the decks". Although the MMs reacted to the announcement with a further mark down in the SP,they do in fact remain keen to buy,at a premium and in size.
I'm continuing to watch closely. I understand yours and Stilolosses view completely and I don't fundamentally disagree with either of you. This is a good company. I admit I was spooked by the large director sale. I note that Mr Ashman has stepped in since with a succession of purchases to reassure the market. So maybe you're right Luke and I was hasty. We'll see. I can foresee me re-entering at some point.
There is still time to get back into STL,should you decide that your exit was a little hasty. The recent endorsement of AuthorBridge by IBM is for me massive as is the fact that IBM are to utilise AB exclusively throughout their organisation to provide guided + fluid authoring solution for their SME’s and casual contributors. Should IBM identify that they could globally scale sales of STL technology then Stilo's days as an independent could be numbered.It was very difficult to buy Stilo shares in any size on Friday afternoon,yet one could sell 250k at a premium. Very interesting times for this micro-cap.
If one wants to get some knowledge around the new Authorbridge product the company are holding a Webinar today at 5.00pm
I agree. This is a good little company that is growing slowly. Stilo is not a quick in and quick out company. Definitely a long term investment. It ticks all the boxes for me BUT it is going to take time for it to continue its revenue and profit growth.. This will definitely happening and will continue to happen. 2016 should be a good year but you need to look at 2017 and 2018 to see what real kind of improvements will happen. Disappointing that the CEO has sold a third of his holdings. If he knew that the share price was going to go higher anytime soon he would not have sold. He also knows though that the share price will move in 2017 and 2018 as do all the longterm investors.
Just returned from a long break with the wife. Difficult time for all shareholders as the general slide has been on going since last October with a few peaks . I'm still in for the long term in this and all my shares except Trafalgar New Homes and Premier Foods. Stilo and many AIM's listed company's are rarely going to take off but make steady progress as they attract interest. .I don't understand the Cotton Eye Joe reference and I hope everyone stays polite, after all discussion and views and part and parcel of the world we live in.Got a sun tan ( I get one sitting in the shade)but avoided the nudist beaches...look better with my clothes on..
Thank you Dibs61 for that as I will look forward to a pat on the back in due course. Large turnover can often be a prelude to corporate activity. https://www.youtube.com/watch?v=VcDy8HEg1QY
Not sure about all the cotton eye joe stuff, maybe a reference to me?! Whatever. Anyway you have to be prepared to change your mind in investing. Its no crime. I sincerely hope you are successful with this investment and i'll be back here to give you a cyber pat on the back if it does. Who knows I may have a few spare quid to put back in. ;) ATB
Dibs61. I do not know to whom the parcel went. I do know that STL were looking for their first institutional investor.
I can't try and interpret actions. The company had an opportunity to provide an explanation but none was given. If you know the answer please go ahead and say? I imagine you're going to say it's to provide stock/liquidity to another willing investor no?
We know where they came from but...... ? You may be sorry to be out Dibs61 were you to know the answer. Nothing has changed and Stilo,imo,remains a superb investment opportunity.
CEO sells a third of his stake @ 5.25p. No reason given. Red Flag - I'm out. Sorry Luke but follow where the money's going. You have to be quick and decisive in this game and I cannot see anything positive in such a move by the company boss. I'll keep it in my watchlist.
Small tick up. Every little helps. Luke - you around?
Nice to see my Divis reinvested here the other day. All future dividends will be reinvested. Best way to compound growth over the long term.
We bounced off 5.37 yesterday afternoon with three solid buys totalling 300k. Good to see.
Although we don't know.Dibs61,based on the pricing guide for AB,the engagement by IBM at enterprise level would generate minimum revenues of US$500k p.a. I consider it doubtful that IBM would contract to pay the going rate,having regard to their technical contributions towards its development over the past two to three years. The view of the STL BOD was that the validation by IBM would open many doors. I see that you too have an interest in palm oil ! Having spent the past seven days exploring all things Liberian/Equatorial Palm OIl/planting and cultivating,I can see the potential for PAL could be very significant. What served to promote your interest in what is a pretty obscure company?
What do we make of the AGM statement? Not much new except to reiterate IBM to deploy Authorbridge in full production this month so good news for sure. What I am not clear about is the potential revenue/sales implications of this deployment. Is this a step change for IBM in terms of their collaboration with Stilo. What does this full deployment really mean for us?
I hope you are soon out and operating at full power Dibs61. I don't think I will manage to attend either,more is the pity. Good to see the small tick up.(7 pence here we come)
AGM tomorrow.... Sadly I can't make it as I am inpatient in hospital. Anyone going?
Breton59 The ultimate company recommendation ? My parents used to hold Harrison and Crossfield many decades ago. For you to suggest this doubtfully managed, tenuously controlled,Libyan focused,nascent operation;you must have something more to tell us. I am aware of a significant Director share purchase at a premium last year and can see the potential to leverage the balance the balance sheet asset.. Can't wait for you to spill a few beans .
After looking at and investing in Tyratech, I thought I would mention Equatorial Palm Oil Co...worth a read up.
MMs seem to want our Stilo shares again, for after a bit of a lull, they are bidding 5.555 pence, in size. Hopefully this might preface the SP test recent highs as the date set for AGM draws nearer.
Wish I could claim it! Sadly not. But certainly mopped up the recent sells. Hopefully we will see another leg up this summer. The chart looks awesome.